- Home
- NRXP vs GSIW Comparison
NRXP vs GSIW Comparison
Compare NRXP & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- GSIW
- Stock Information
- Founded
- NRXP 2015
- GSIW 2016
- Country
- NRXP United States
- GSIW Hong Kong
- Employees
- NRXP N/A
- GSIW N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- GSIW
- Sector
- NRXP Health Care
- GSIW
- Exchange
- NRXP Nasdaq
- GSIW Nasdaq
- Market Cap
- NRXP 32.6M
- GSIW 27.2M
- IPO Year
- NRXP N/A
- GSIW 2023
- Fundamental
- Price
- NRXP $3.37
- GSIW $1.56
- Analyst Decision
- NRXP Strong Buy
- GSIW
- Analyst Count
- NRXP 4
- GSIW 0
- Target Price
- NRXP $28.50
- GSIW N/A
- AVG Volume (30 Days)
- NRXP 284.1K
- GSIW 2.1M
- Earning Date
- NRXP 08-13-2025
- GSIW 01-01-0001
- Dividend Yield
- NRXP N/A
- GSIW N/A
- EPS Growth
- NRXP N/A
- GSIW N/A
- EPS
- NRXP N/A
- GSIW N/A
- Revenue
- NRXP N/A
- GSIW $1,313,795.00
- Revenue This Year
- NRXP N/A
- GSIW N/A
- Revenue Next Year
- NRXP N/A
- GSIW N/A
- P/E Ratio
- NRXP N/A
- GSIW N/A
- Revenue Growth
- NRXP N/A
- GSIW N/A
- 52 Week Low
- NRXP $1.10
- GSIW $0.35
- 52 Week High
- NRXP $6.01
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- NRXP 58.22
- GSIW 72.24
- Support Level
- NRXP $2.90
- GSIW $1.43
- Resistance Level
- NRXP $3.53
- GSIW $1.62
- Average True Range (ATR)
- NRXP 0.21
- GSIW 0.15
- MACD
- NRXP -0.04
- GSIW -0.02
- Stochastic Oscillator
- NRXP 66.20
- GSIW 47.62
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.